Everyone seems to assume the COMPANY will be bough

Everyone seems to assume the COMPANY will be bought out as an entity, but don't you think it's possible that CTIX will LICENSE Kevetrin or Prurisol, getting a slug of cash up front and a royalty agreement, in return for handing over development rights to big pharma? This would enable them to get a similar agreement for the other drug, while Dr. Menon can continue developing the other stuff in the pipeline. I would think you would get more by selling each product separately, rather than the entire company. Seems to me that a scientist who is developing these things wouldn't want to just sign off on everything at once, and not get to keep overseeing the work on the other drugs.

Of course I suppose he could also sign a deal with a big pharma that kept him in charge of development of the rest of the pipeline.